DAFNA CAPITAL MANAGEMENT LLC – Syndax Pharmaceuticals, Inc. Transaction History
DAFNA CAPITAL MANAGEMENT LLC portfolio value:
$8.54M
portfolio value
DAFNA CAPITAL MANAGEMENT LLC quarter portfolio value change:
+24.90%
quarter
Syndax Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -4.18% | -15.5K shares | 1.40M | $24.03 | 355.48K |
Q2 2022 | share | Decrease | -0.27% | -1K shares | 673K | $19.24 | 370.98K |
Q1 2022 | share | Increase | +25.44% | 75.45K shares | -26K | $17.38 | 371.98K |
Q4 2021 | share | Increase | +267.44% | 215.83K shares | 4.94M | $21.78 | 296.53K |
Q3 2021 | share | Decrease | -45.36% | -67K shares | -994K | $19.11 | 80.70K |
Q2 2021 | share | Increase | +156.87% | 90.20K shares | 1.25M | $17.17 | 147.70K |
Q1 2021 | share | Increase | +475.00% | 47.5K shares | 1.06M | $22.36 | 57.5K |
Q4 2020 | share | Decrease | -90.26% | -92.71K shares | -1.29M | $22.24 | 10K |
Q3 2020 | share | Decrease | -71.47% | -257.28K shares | -3.81M | $14.76 | 102.71K |
Q2 2020 | share | Increase | 0.00% | 360K shares | 5.33M | $14.82 | 360K |